Catherine Mackey has been elected to Sequenom's board, where she will serve on the audit and nominating, and corporate governance committees. Mackey is CEO of Cyprus Therapeutics and was previously senior VP of worldwide R&D at Pfizer. Before that, she was VP of strategic alliances at the pharma firm.
She is a special advisor to Fortis Advisors and is a director at Rady Children's Hospital. Mackey also chairs the board of Cour Pharmaceutical Development and is on the boards of Evolve Biosystems and Viventia Bio.